Pharmacometric assessment of single dose tafenoquine to prevent Plasmodium vivax relapse
▶

Pharmacometric assessment of single dose tafenoquine to prevent Plasmodium vivax relapse

Dr James Watson from OUCRU, now IDDO's Associate Director, tells us about the reassessment of tafenoquine pharmacometrics. This talk is part of the webinar 'Radical cure of vivax malaria: can we do better?', recorded on the 3rd February 2023. This video has been captioned by IDDO.